MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-06-2026
STERIS plc Retained Earnings 2011-2026 | STE
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings STERIS plc
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.48 B | 2.09 B | 1.91 B | 2 B | 1.94 B | 1.65 B | 1.34 B | 1.15 B | 954 M | 939 M | 1.19 B | 1.11 B | 1.03 B | 914 M | 817 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.48 B | 817 M | 1.43 B |
Quarterly Retained Earnings STERIS plc
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.86 B | 2.73 B | 2.6 B | 2.48 B | 2.39 B | 2.27 B | 2.18 B | 2.09 B | 2.13 B | 2.05 B | 1.98 B | 1.91 B | 1.77 B | 1.7 B | 2.06 B | 2 B | 1.99 B | 1.89 B | 1.87 B | 1.94 B | 1.87 B | 1.79 B | 1.7 B | 1.66 B | 1.54 B | 1.47 B | 1.4 B | 1.34 B | - | - | - | 1.15 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.86 B | 1.15 B | 1.96 B |
Retained Earnings of other stocks in the Medical instruments industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
AtriCure
ATRC
|
-413 M | $ 29.85 | 1.05 % | $ 1.43 B |  USA |
 |
Atrion Corporation
ATRI
|
382 K | - | - | $ 810 M | USA |
 |
AngioDynamics
ANGO
|
-429 M | $ 10.6 | -1.03 % | $ 433 M | USA |
 |
Luminex Corporation
LMNX
|
83.8 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
-120 M | - | -9.52 % | $ 20.6 M | USA |
 |
Alcon
ALC
|
19.4 B | $ 77.32 | -1.5 % | $ 40.4 B |  Schweiz |
 |
Antares Pharma, Inc.
ATRS
|
-223 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
548 M | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
-11.9 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
2.13 B | - | -0.05 % | $ 10.3 B | USA |
 |
The Cooper Companies
COO
|
7.64 B | $ 69.92 | -2.24 % | $ 13.9 B | USA |
 |
Harvard Bioscience
HBIO
|
-146 M | $ 0.47 | -4.15 % | $ 19.9 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.13 B | - | -0.02 % | $ 16.3 B | USA |
 |
Glaukos Corporation
GKOS
|
-599 M | $ 97.02 | -0.79 % | $ 4.7 B | USA |
 |
Becton, Dickinson and Company
BDX
|
16.6 B | $ 159.36 | -0.17 % | $ 45.8 B | USA |
 |
ICU Medical
ICUI
|
691 M | $ 125.85 | -2.28 % | $ 3.1 B | USA |
 |
InfuSystem Holdings
INFU
|
-59.3 M | $ 9.31 | -0.85 % | $ 192 M | USA |
 |
iRhythm Technologies
IRTC
|
-803 M | $ 113.0 | -1.46 % | $ 3.62 B | USA |
 |
Intuitive Surgical
ISRG
|
7.01 B | $ 472.16 | -1.48 % | $ 169 B | USA |
 |
Haemonetics Corporation
HAE
|
352 M | $ 59.92 | 0.72 % | $ 3.02 B | USA |
 |
electroCore
ECOR
|
-165 M | $ 6.14 | -3.0 % | $ 33.9 K | USA |
 |
Isoray
ISR
|
-232 M | - | 0.03 % | $ 108 M | USA |
 |
Masimo Corporation
MASI
|
1.49 B | $ 175.49 | -0.01 % | $ 9.35 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-262 M | $ 11.56 | -2.12 % | $ 28 M | USA |
 |
Repro Med Systems
KRMD
|
-32 M | $ 4.28 | -0.7 % | $ 198 M | USA |
 |
Baxter International
BAX
|
13.7 B | $ 17.4 | -3.36 % | $ 8.93 B | USA |
 |
NeuroMetrix
NURO
|
-218 M | - | 5.05 % | $ 9.02 M | USA |
 |
BioLife Solutions
BLFS
|
-335 M | $ 18.36 | 1.16 % | $ 846 M | USA |
 |
Envista Holdings Corporation
NVST
|
-440 M | $ 24.61 | -3.26 % | $ 4.13 B | USA |
 |
Nephros
NEPH
|
-144 M | $ 3.5 | -7.89 % | $ 36.4 M | USA |
 |
Merit Medical Systems
MMSI
|
824 M | $ 69.95 | 2.61 % | $ 4.14 B | USA |
 |
OraSure Technologies
OSUR
|
-172 M | $ 2.97 | -3.88 % | $ 218 M | USA |
 |
LeMaitre Vascular
LMAT
|
185 M | $ 108.06 | 1.43 % | $ 2.45 B | USA |
 |
Pro-Dex
PDEX
|
35.9 M | $ 48.46 | 3.5 % | $ 159 M | USA |
 |
Microbot Medical
MBOT
|
-79.5 M | $ 2.69 | -1.47 % | $ 27.4 M |  Israel |
 |
Predictive Oncology
POAI
|
-180 M | - | - | $ 31.1 M | USA |
 |
Repligen Corporation
RGEN
|
433 M | $ 114.2 | 0.39 % | $ 6.36 M | USA |
 |
ResMed
RMD
|
3.61 B | $ 230.84 | -0.68 % | $ 33.7 B | USA |
 |
Retractable Technologies
RVP
|
26.7 M | $ 0.71 | 2.62 % | $ 21.3 M | USA |
 |
Pulse Biosciences
PLSE
|
-463 M | $ 21.57 | 1.27 % | $ 1.45 B | USA |
 |
STAAR Surgical Company
STAA
|
-148 M | $ 18.84 | 2.45 % | $ 934 M | USA |
 |
Stereotaxis
STXS
|
-583 M | $ 1.89 | 0.27 % | $ 172 M | USA |
 |
Teleflex Incorporated
TFX
|
3.15 B | $ 107.32 | -0.87 % | $ 4.79 B | USA |
 |
Utah Medical Products
UTMD
|
138 M | $ 63.28 | 1.02 % | $ 230 M | USA |
 |
West Pharmaceutical Services
WST
|
4.37 B | $ 235.46 | 1.89 % | $ 17 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
-1.56 B | $ 11.54 | -2.2 % | $ 2.3 B | USA |
 |
Milestone Scientific
MLSS
|
-128 M | $ 0.28 | -3.75 % | $ 22.3 M | USA |